
Reset all filters
01 3Baxter Healthcare Corporation
02 2Baxter Healthcare South Africa (Pty) Ltd
03 2CSL Behring
04 3Grifols International
05 3OMRIX BIOPHARMACEUTICALS LTD
06 2Octapharma
Reset all filters
01 1Clottable Protein Human+Human Thrombin 1Ml 2 Units Use Epilesionale
02 1Clottable Protein Human+Human Thrombin 2Ml 2 Units Use Epilesionale
03 1Clottable Protein Human+Human Thrombin 5Ml 2 Units Use Epilesionale
04 2KIT
05 2POW
06 3POWDER FOR SOLUTION
07 5SOLUTION
Reset all filters
01 2Originator
02 1Prescription
03 9Schedule D
04 3Blank
Reset all filters
01 1ARTISS
02 1BERIPLEX P/N 1000
03 1BERIPLEX P/N 500
04 3Evicel
05 2OCTAPLEX
06 2TISSEEL
07 2Tisseel
08 3VISTASEAL
Reset all filters
01 10Canada
02 3Italy
03 2South Africa
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TISSEEL
Dosage Form : KIT
Dosage Strength : 500UNIT/ML
Packaging : 2ML/4ML/10ML
Approval Date :
Application Number : 2326132
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ARTISS
Dosage Form : SOLUTION
Dosage Strength : 4UNIT/ML
Packaging : 2ML/4ML/10ML (TOTAL VOLUME)
Approval Date :
Application Number : 2326167
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : TISSEEL
Dosage Form : SOLUTION
Dosage Strength : 500UNIT/ML
Packaging : 2ML/4ML/10ML (TOTAL VOLUME)
Approval Date :
Application Number : 2326175
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : BERIPLEX P/N 500
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 800UNIT
Packaging : 30ML
Approval Date :
Application Number : 2359251
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : BERIPLEX P/N 1000
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1600UNIT
Packaging : 50ML
Approval Date :
Application Number : 2410826
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : VISTASEAL
Dosage Form : SOLUTION
Dosage Strength : 500UNIT/1ML
Packaging :
Approval Date :
Application Number : 2514222
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : VISTASEAL
Dosage Form : SOLUTION
Dosage Strength : 1000UNIT/2ML
Packaging :
Approval Date :
Application Number : 2514230
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : VISTASEAL
Dosage Form : SOLUTION
Dosage Strength : 2500UNIT/5ML
Packaging :
Approval Date :
Application Number : 2514257
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : OCTAPLEX
Dosage Form : KIT
Dosage Strength : 760UNIT/VIAL
Packaging : 20ML
Approval Date :
Application Number : 2294664
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : OCTAPLEX
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 1520UNIT/VIAL
Packaging : 40ML
Approval Date :
Application Number : 2434970
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info :
Registration Country : Italy
Brand Name : Evicel
Dosage Form : Clottable Protein Human+Human Thrombin 1Ml 2 Units Use Epilesionale
Dosage Strength : 2 vials epilesionale use 1 ml 50-90 mg/ml + 800-1200 IU/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Evicel
Dosage Form : Clottable Protein Human+Human Thrombin 2Ml 2 Units Use Epilesionale
Dosage Strength : 2 vials epilesionale use 2 ml 50-90 mg/ml + 800-1200 IU/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Evicel
Dosage Form : Clottable Protein Human+Human Thrombin 5Ml 2 Units Use Epilesionale
Dosage Strength : 2 vials epilesionale use 5 ml 50-90 mg/ml + 800-1200 IU/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Tisseel
Dosage Form : POW
Dosage Strength : 500IU/ml
Packaging : 2X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Tisseel
Dosage Form : POW
Dosage Strength : 500IU/ml
Packaging : 4X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF